flipper44, thx, your layer peeling analysis is so helpful to more complete understanding of the results while waiting for the publication, which should provide a complete picture.
When thinking of these treatment realities one can easily see why doctors like Dr Ashkan cannot wait to have a significantly positive tool to help their patients with to combat this terrible disease. There is so much to appreciate about DCVax-L vs GBM that should still come out short and long term.
The challenge here is the timing of advancing this medical science. We now need combination trial results, we need Direct studies, we need to understand much, much more about this platform and in THIS decade. Next steps are so critically important at every level.
GLTA
Market Data 
Markets 
AI
